Opsumit 10 MG

Ended Awarded Last action

Contract number
36C24526N0477
Awardee
Awarding agency
Obligated
$47,052

Award facts

Contract value 100% obligated
$47,052.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Lake Mary, FL 32746, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $23,526
Original award $23,526

About this award

Veterans Integrated Service Network 5 issued a $47,052.30 delivery order to Actelion Pharmaceuticals US, Inc. on April 3, 2026, under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB) for OPSUMIT 10 MG pharmaceutical supply.

The FSS-61-IB is a multiple-award schedule contract for pharmaceuticals and drugs valued at $219.1 million with a period of performance from August 1, 2024, through July 31, 2029. Place of performance is Lake Mary, FL. The order is priced on a firm fixed-price basis with an ultimate completion date of May 15, 2026.

Quick answers

Who was awarded contract 36C24526N0477?

36C24526N0477 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 3, 2026.

How much is contract 36C24526N0477 worth?

The government has obligated $47,052 on 36C24526N0477.

Is contract 36C24526N0477 an order under another contract?

Yes. 36C24526N0477 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24526N0477 competed?

The extent of competition for 36C24526N0477 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award